DRKS00025030招募中不适用
Prospective non-interventional registry study entitled:Peripartum outcome in vaginally targeted final pelvic births and influencing factors
Zentrum für Frauenheilkunde und Geburtshilfe Universitätsklinikum Frankfurt am Main0 个研究点目标入组 1,500 人开始时间: 2021年10月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •PATIENT REGISTRATION:
- •- Mother's date of birth (month/year): (mm/yyyy)
- •- Date of delivery (month/year): (mm/yyyy)
- •- Birth book number
- •BASIC DATA:
- •- Gravidity (number) / parity (number) / abortion/interruption (number) / EUG (extrauterine pregnancy) (Z
- •- Height (in cm): (number without decimal place)
- •- Weight before SS (in kg): (number without decimal place)
- •- BMI (before SS)
- •- Pelvic diagnosis
- •? CVO (in cm)
- •- Condition after uterine surgery/sectio? (yes/no)
- •- Diseases/complications during pregnancy? (Yes/no) Case yes: type of
- •Disease/complication?
- •? Preeclampsia (yes/no)
- •? Gestational diabetes (yes/no).
- •- GDM, insulin dependent (yes/no)
- •- GDM, diet-controlled (yes/no)
- •? Preterm labor/cervical insufficiency (yes/no)
- •? Cervical insufficiency (cerclage, pressor insertion) (yes/no)
- •? Preterm labor indicators (rupture, prolapse, hemorrhage, opening of uterine orifice,
- •Contractions) (yes/no)
- •? abnormal condition of uterus and female genital tract (U.bicornis,
- •U.subseptus, fibroids, U.myomatosus, vagina subsepta, scars) (yes/no).
- •? Placental disorders(yes/no) If yes: what type of placental disorders?
- •- Placenta praevia (yes/no).
- •- Placental insufficiency, abruption,hemorrhage (yes/no).
- •? PPROM (premature rupture of membranes < SSW 37+0) (yes/no).
- •? SGA/IUGR (yes/no).
- •? Physical limitation (malformations, orthopedic problems, short stature,
- •Heart defect)
- •? Blood coagulation (factor disorders, thrombosis, embolism, thrombocytopenia)
- •? (Systemic) pre-existing conditions (e.g., hyper-/hypotension, hyper-/hypothyroidism,
- •Diabetes, anemia, obesity, neurodermatitis) (yes/no).
- •? chronic infections (hepatitis,HIV) (yes/no)
- •? Alcohol/drug abuse, methadone substitution
- •? Other diseases/complications (free field) (yes/no)
- •? If no: above fields visible but not editable.
- •- Time of delivery: SSW [number+number] - e.g., 37+6
- •- TYPE of Breech
- •? complete breech = both legs bent upwards (yes/no)
- •? incomplete rear- foot- breech = one foot up, one foot down(yes/no)
- •? complete rear- foot- breech= both feet down (yes/no)
- •? baby standing in the uterus (yes/no)
- •? legs and head to the right/ left, belly or back down (yes/no)
- •- Mode of delivery:
- •? Vaginal spontaneous delivery (yes/no)
- •? Primary sectio(yes/no)
- •? Secondary sectio (yes/no)
- •? Emergency sectio (yes/no)
- 另有 33 项未显示
排除标准
- •missing patient's consent
- •pathology in pregnancy
- •gestational diabetes
- •Uterine malformations
- •Uterine surgery with caval opening
- •Placental abnormalities
- •Pelvic abnormalities
- •Fetal growth retardation
- •Transverse position
- •Fetal malformations
研究者
相似试验
进行中（未招募）
不适用
The REPLACE Registry for Cholbam® (Cholic Acid)Bile Acid Synthesis DisordersNCT03115086Mirum Pharmaceuticals, Inc.55
已完成
不适用
Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma PatientsMetastatic MelanomaNCT06369428Novartis1,795
已完成
不适用
A prospective, non-interventional study to investigate the effectiveness of a recombinant fusion protein linking coagulation Factor IX with recombinant albumin (rIX-FP) in patients with hemophilia BD67Hereditary factor IX deficiencyDRKS00015079CSL Behring GmbH73
招募中
不适用
Prospective registry study to record the diagnosis and treatment of diabetic sensorimotor polyneuropathyG63.2Diabetic polyneuropathyDRKS00017845WÖRWAG Pharma GmbH & Co. KG1,100
尚未招募
不适用
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritisDRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40